Skip to main content
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
96.66
+4.57 (4.96%)
At close: Mar 9, 2026, 4:00 PM EDT
96.25
-0.41 (-0.42%)
After-hours: Mar 9, 2026, 6:18 PM EDT

Protagonist Therapeutics Revenue

In the year 2025, Protagonist Therapeutics had annual revenue of $46.02M, down -89.41%. Protagonist Therapeutics had revenue of $7.44M in the quarter ending December 31, 2025, a decrease of -95.64%.

Revenue (ttm)
$46.02M
Revenue Growth
-89.41%
P/S Ratio
134.08
Revenue / Employee
$348,606
Employees
132
Market Cap
6.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202546.02M-388.42M-89.41%
Dec 31, 2024434.43M374.43M624.06%
Dec 31, 202360.00M33.42M125.73%
Dec 31, 202226.58M-776.00K-2.84%
Dec 31, 202127.36M-1.27M-4.44%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 1.73B
Caris Life Sciences 812.03M
Mirum Pharmaceuticals 521.31M
Rhythm Pharmaceuticals 189.76M
Kymera Therapeutics 39.21M
Arcellx 22.29M
CRISPR Therapeutics AG 3.51M
Revenue Rankings

PTGX News

More News